Streetbeat News

Corporate Responsibility

QCOM

Marques Brownlee's review of the Humane AI Pin has sparked debate on social media about the impact of negative reviews on companies. Brownlee, known as MKBHD, has previously influenced companies like Razer to improve their products. His review of the Humane AI Pin, described as the 'worst product' he's ever reviewed, raises questions about the role of reviews in a product's success. The Humane AI Pin, backed by notable investors including OpenAI's Sam Altman, Tiger Global, and Qualcomm Ventures, is a ChatGPT-powered device.

Portfolio Pulse from Rounak Jain

April 17, 2024 | 1:07 pm

MCHI

Chinese exporters at the Canton Fair are facing challenges despite China's 5.3% economic growth in Q1, including a decline in exports and producer prices. Increased economic and political tensions with the U.S., global trade slowdowns, and manufacturing overcapacity are key issues. Some sectors, like high-tech, remain optimistic due to government support. Trade tensions could worsen with potential U.S. tariffs and blacklisting of Chinese companies. The iShares MSCI China ETF (MCHI) saw a 1.02% dip.

Portfolio Pulse from Benzinga Neuro

April 17, 2024 | 12:58 pm

PTIX

Protagenic Therapeutics, Inc. (NASDAQ:PTIX) announced that COO Dr. Andrew Slee will present on their drug candidate PT00114 at the Peptide Based Therapeutic Summit in Boston on April 23, 2024. The presentation will highlight PT00114's ability to cross the blood-brain barrier, offering potential in neuro-psychiatric treatment. Preclinical data and ongoing clinical safety trial insights will be shared, emphasizing the drug's innovative approach and efficacy.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 12:47 pm

NRXP

NRx Pharmaceuticals released data indicating that in rodent models, their drug NRX-101 showed no impact on gut or vaginal flora. This finding is significant for the drug's safety profile, as it suggests that NRX-101 does not disrupt the microbiome, a common concern for new medications.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 12:35 pm

XPER

Xperi Inc. has issued a letter to its stockholders, urging them to vote for its five director nominees at the upcoming Annual Meeting on May 24, 2024. The letter highlights Xperi's transformation from a semiconductor IP licensing company to a consumer entertainment technology company, focusing on connected TV advertising, streaming television, and in-vehicle infotainment. Xperi's board and management have driven this change, notably through acquisitions like DTS and the merger with TiVo. The company has seen five consecutive quarters of year-over-year revenue growth and expects continued growth and margin expansion. Xperi is contesting Rubric Capital's campaign to replace two directors, arguing that Rubric's nominees lack relevant experience and could hinder the company's progress.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 12:35 pm

AAPL

Apple Inc. is considering expanding its manufacturing base to Indonesia as part of its strategy to diversify production and reduce dependency on Chinese manufacturing. This follows discussions between CEO Tim Cook and Indonesian President Joko Widodo. The move is in line with Apple's efforts to explore new markets and enhance global supply chain resilience, with Vietnam and India already playing significant roles in Apple's manufacturing diversification.

Portfolio Pulse from Benzinga Neuro

April 17, 2024 | 12:24 pm

PLCE

The Children's Place has entered into a new financing agreement with Mithaq Capital, its majority shareholder, for a $90M unsecured and subordinated term loan, to be funded by April 19, 2024.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 12:01 pm

SYRA

Syra Health has announced the continuation of its partnership with Maricopa County, Arizona, for a third public health training session. This session will focus on cultural humility, emphasizing the importance of understanding and respecting diverse cultural backgrounds in healthcare settings.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 11:55 am

BE

Bloom Energy announced the appointment of Daniel Berenbaum as its new Chief Financial Officer, effective April 29. Berenbaum will take over from Greg Cameron, who will stay until mid-May 2024 to ensure a smooth transition.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 11:33 am

ATHE

Alterity Therapeutics presented three posters at the American Academy of Neurology 2024 Annual Meeting, showcasing their work on Parkinson's Disease and Multiple System Atrophy. The presentations included initial biomarker data and baseline characteristics from their ATH434-201 Phase 2 clinical trial.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 11:26 am